InvestorsHub Logo

nidan7500

09/25/17 11:48 AM

#121543 RE: falconer66a #121542

Curious, of course, that lame efforts such this get NIH funding, inasmuch as Anavex has a drug with so much greater potential




Yes, it is curious how money finds a way of getting to certain points in the U.S.healthcare structure. Why A2-73 remains in the shadows is a puzzle to some degree. Funding from NIH suggests credibility for the study even though they should know a study of (possibly) permanent AD treatment is not funded. What are we missing here?